Clinical Trial Update: A Clinical Study of Mass Balance of [14C]HRS-7535 [Phase 1]

View source ↗

Summary

This is a Phase 1 mass balance study of the investigational drug HRS-7535 (14C-labeled) conducted by Shandong Suncadia Medicine Co., Ltd., studied in individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus, Weight Loss | Phase 1 | Status: COMPLETED